Cyclosporin A enhances survival, ameliorates brain damage, and prevents secondary mitochondrial dysfunction after a 30-minute period of transient cerebral ischemia

被引:64
作者
Li, PA [1 ]
Kristián, T [1 ]
He, QP [1 ]
Siesjö, BK [1 ]
机构
[1] Queens Med Ctr, Ctr Study Neurol Dis, Honolulu, HI 96813 USA
关键词
cerebral ischemia; cyclosporin A; mitochondrial function; mitochondrial respiration; cerebral blood flow; pathology;
D O I
10.1006/exnr.2000.7459
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cyclosporin A (CsA) has been shown to be efficacious in protecting against ischemic injury after short periods (5 to 10 min) of forebrain ischemia. The present experiments were undertaken to study if a long period of forebrain ischemia (30 min), induced at a brain temperature of 37 degrees C, is compatible with survival and if the brain damage incurred can be ameliorated by CsA. The results showed that animals subjected to 30 min of forebrain ischemia at a brain temperature of 37 degrees C failed to survive after the first 24 h of recovery and showed extensive neuronal necrosis in all selectively vulnerable regions after 1 day of survival. CsA, when injected in combination with an intracerebral lesion to open the blood-brain barrier, markedly prolonged the survival time. CsA-injected animals also showed amelioration of histological lesions, an effect that was sustained for at least 4 days. Experiments with mitochondria isolated from the neocortex and hippocampus showed that state 3 respiratory rates decreased during ischemia, recovered after 1 and 3 h of recirculation, and then showed a secondary decline at 6 h. Administration of CsA prevented this secondary decline. Measurements of neocortical cerebral blood flow showed that there was no secondary hypoperfusion prior to secondary mitochondrial dysfunction, implying that changes in blood flow may not be responsible for the rapidly developing, secondary brain damage. The results thus demonstrate that if brain temperature is upheld at 37 degrees C, a 30-min period of ischemia is not compatible with survival after the first day of recovery, and gross histopathological damage develops within that period. CsA was efficacious in prolonging animal survival, ameliorating brain damage, and preventing the secondary mitochondrial dysfunction. Since CsA blocks: the mitochondrial permeability transition pore its action may, at least in part, be on mitochondrial integrity and function. (C) 2000 Academic Press.
引用
收藏
页码:153 / 163
页数:11
相关论文
共 47 条
[1]  
ALMEIDA A, 1995, J NEUROCHEM, V65, P1698
[2]   PERMEABILITY OF THE BLOOD-BRAIN-BARRIER TO THE IMMUNOSUPPRESSIVE CYCLIC PEPTIDE CYCLOSPORINE-A [J].
BEGLEY, DJ ;
SQUIRES, LK ;
ZLOKOVIC, BV ;
MITROVIC, DM ;
HUGHES, CCW ;
REVEST, PA ;
GREENWOOD, J .
JOURNAL OF NEUROCHEMISTRY, 1990, 55 (04) :1222-1230
[3]   RECENT PROGRESS ON REGULATION OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE - A CYCLOSPORINE-SENSITIVE PORE IN THE INNER MITOCHONDRIAL-MEMBRANE [J].
BERNARDI, P ;
BROEKEMEIER, KM ;
PFEIFFER, DR .
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1994, 26 (05) :509-517
[4]   The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death [J].
Bernardi, P .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1996, 1275 (1-2) :5-9
[5]   MK 801 and dexamethasone reduce both tumor necrosis factor levels and infarct volume after focal cerebral ischemia in the rat brain [J].
Bertorelli, R ;
Adami, M ;
Di Santo, E ;
Ghezzi, P .
NEUROSCIENCE LETTERS, 1998, 246 (01) :41-44
[6]  
BUCHAN A, 1991, J NEUROSCI, V11, P1049
[7]   Activity of mitochondrial respiratory chain enzymes after transient focal ischemia in the rat [J].
Canevari, L ;
Kuroda, S ;
Bates, TE ;
Clark, JB ;
Siesjo, BK .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1997, 17 (11) :1166-1169
[8]   METHOD FOR THE LOCALIZATION OF SITES FOR OXIDATIVE PHOSPHORYLATION [J].
CHANCE, B ;
WILLIAMS, GR .
NATURE, 1955, 176 (4475) :250-254
[9]   ON THE INVOLVEMENT OF A MITOCHONDRIAL PORE IN REPERFUSION INJURY [J].
CROMPTON, M ;
ANDREEVA, L .
BASIC RESEARCH IN CARDIOLOGY, 1993, 88 (05) :513-523
[10]  
CROMPTON M, 1988, BIOCHEM J, V255, P357